Patents Assigned to Taraxos Inc.
  • Publication number: 20140194514
    Abstract: Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies.
    Type: Application
    Filed: January 14, 2014
    Publication date: July 10, 2014
    Applicant: TARAXOS INC.
    Inventors: Richard WOLICKI, Stanley KIM
  • Patent number: 8629184
    Abstract: Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies.
    Type: Grant
    Filed: September 25, 2009
    Date of Patent: January 14, 2014
    Assignee: TARAXOS, Inc.
    Inventors: Richard Wolicki, Stanley Kim
  • Publication number: 20120270916
    Abstract: Compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy are described.
    Type: Application
    Filed: March 16, 2012
    Publication date: October 25, 2012
    Applicant: TARAXOS INC.
    Inventor: Richard Wolicki
  • Patent number: 8137711
    Abstract: Methods and compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and methods for administering the compositions to treat various neuropathies.
    Type: Grant
    Filed: March 29, 2010
    Date of Patent: March 20, 2012
    Assignee: Taraxos Inc.
    Inventor: Richard Wolicki
  • Publication number: 20110178177
    Abstract: Topical treatments for neuropathy are described. The treatments include topical formulations of NMDA antagonists and one additional active ingredient. In one example, the formulation includes ketamine and gabapentin for the treatment of a subject's neuropathy. These transdermal or topical compositions provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and can be administered to subjects to treat various neuropathies.
    Type: Application
    Filed: September 25, 2009
    Publication date: July 21, 2011
    Applicant: TARAXOS INC.
    Inventors: Richard Wolicki, Stanley Kim
  • Publication number: 20100184817
    Abstract: Methods and compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and methods for administering the compositions to treat various neuropathies.
    Type: Application
    Filed: March 29, 2010
    Publication date: July 22, 2010
    Applicant: TARAXOS INC.
    Inventor: Richard Wolicki
  • Patent number: 7687080
    Abstract: Methods and compositions for the topical or transdermal treatment of neuropathy. More particularly, transdermal or topical compositions including a combination of ingredients that provide a surprising degree of effective relief from the symptoms of peripheral neuropathy and methods for administering the compositions to treat various neuropathies.
    Type: Grant
    Filed: November 25, 2002
    Date of Patent: March 30, 2010
    Assignee: Taraxos Inc.
    Inventor: Richard Wolicki